" class="no-js "lang="en-US"> Partnerships Archives - Page 44 of 52 - Medtech Alert
Tuesday, September 30, 2025

Sort by:

Date

Top Post

ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients

ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]

SomaLogic Announces Strategic Collaboration with University Hospitals Cleveland Medical Center to Treat Diabetic Patients at High Risk of Cardiovascular Disease

SomaLogic (NASDAQ: SLGC), a leader in data-driven proteomics technology, today announced a strategic collaboration with […]

Code Ocean Selected by Lantern Pharma to Power A.I. and Computational Biology Research & Data-Driven Oncology Drug Development Collaborations

Lantern Pharma (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR® artificial intelligence (“A.I.”) platform […]

BHF Teams Up With The Francis Crick Institute to Bolster Cardiovascular Research

BHF have teamed up with the Francis Crick Institute to improve understanding of cardiovascular health […]

Bicycle Therapeutics Announces Expansion of Genentech Immuno-Oncology Collaboration

Bicycle Therapeutics plc (NASDAQ: BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics […]

Heidelberg Ion Beam Therapy Center Treats First Patient Using Helium Ion Therapy with RayStation

Heidelberg Ion Beam Therapy Center (HIT) has treated its first patient using helium ion therapy […]

Hummingbird Bioscience to Collaborate with Merck on Clinical Trial of Anti-VISTA Antibody HMBD-002 in Combination with KEYTRUDA® (Pembrolizumab) for Treatment of Cancer

Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing precision therapies against hard-to-drug targets […]

Antengene Enters into a Research Collaboration & License Option Agreement with LegoChem Biosciences for New Antibody-Drug Conjugate Candidates

Antengene Corporation Limited (“Antengene”, SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing […]

Hackensack Meridian Health and Google Expand Relationship to Improve Patient Care

Hackensack Meridian Health and Google today announced the two organizations are expanding their relationship to improve patient […]

Viome Life Sciences Announces Expansion of Collaboration with GSK into New Therapeutic Interventions for Cancers and Autoimmune Diseases

Viome Life Sciences, a mission-driven systems biology company aiming to help individuals improve their health, […]

Babylon Announces New Collaboration with Microsoft to Drive Healthcare Innovation and Improve Health Access and Affordability Around the World

Babylon, a world leading digital-first, value-based care company today announced a collaboration with Microsoft to […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more